The primary goal of diabetes mellitus treatment was to eliminate clinically noticeable symptoms of diabetes mellitus decompensation (polyuria, polydipsia, decay, recurrent infections, especially fungal infections). Only after recognizing the importance of asymptomatic hyperglycemia and other changes for the patient's prognosis, the basic goal of therapy became achieving normal blood glucose levels and compensating for all other metabolic abnormalities (especially dyslipidemia), normalizing blood pressure, achieving normal weight.
This treatment strategy with specific goals is, in the current opinion, a basic condition and prerequisite for fulfilling the general goal of diabetes treatment - reducing the morbidity and mortality of the diabetic population while improving the quality of life. Rising blood glucose levels have been shown to increase the risk of progression or progression of microvascular - and, according to recent research, clearly macrovascular complications.1 2.3 In the following text, the importance of compensation assessment is related to the treatment of type 2 diabetes.